Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: systematic review and budget impact analysis

Boucher M, McAuley L, Brown A, Keely E, Skidmore B
Record ID 32003000019
English, French
Authors' objectives:

The aims of this report are:

1. To evaluate the evidence that compares rosiglitazone or pioglitazone with other oral anti-diabetic agents (including insulin), either when used alone or when added to a non-thiazolidionedione agent in the treatment of type 2 diabetes.

2. To determine the impact of listing thiazolidinediones on the budget of provincial drug plans in Canada.

Authors' recommendations: When used alone, both rosiglitazone and pioglitazone have effects similar to comparator drugs on glycosylated hemoglobin (HbA1c) and fasting plasma glucose (FPG), based on the findings from a small number of comparative trials. When added to another anti-diabetic agent, the effect on HbA1c and FPG is significantly greater than continuing therapy with the other anti-diabetic agent alone. This is consistent with the work of others that shows combining two anti-diabetic agents provides a greater effect than using one alone. Both drugs were generally well tolerated during the trials reviewed; only a few cases of heart failure and severe hypoglycemia (when added to another agent) were reported. No liver toxicity was observed. Long-term trials are required to evaluate their effect on the development of diabetic complications and long-term safety.
Authors' methods: Systematic review
Project Status: Completed
URL for project: https://www.ccohta.ca/
Year Published: 2002
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Costs and Cost Analysis
  • Hypoglycemic Agents
  • Diabetes Mellitus
Organisation Name: Canadian Coordinating Office for Health Technology Assessment
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.